Literature DB >> 18802061

Early growth response genes regulate B cell development, proliferation, and immune response.

Murali Gururajan1, Alan Simmons, Trivikram Dasu, Brett T Spear, Christopher Calulot, Darrell A Robertson, David L Wiest, John G Monroe, Subbarao Bondada.   

Abstract

Egr-1 (early growth response gene-1) is an immediate early gene encoding a zinc finger motif-containing transcription factor. Upon cross-linking of BCR, mature B cells undergo proliferation with an increase in Egr-1 message. Immature B lymphoma cells that express Egr-1 message and protein constitutively are growth inhibited when Egr-1 is down-regulated by negative signals from BCR or by antisense oligonucleotides. To test the hypothesis that Egr-1 is important for B cell development, we examined B cells from primary and secondary lymphoid organs in Egr-1(-/-) mice. Marginal zone B cell development was arrested in these mice, whereas the B cells in all other compartments were increased. To test the hypothesis that Egr-1 function may be partially compensated by other Egr family members, we developed transgenic mice expressing a dominant negative form of Egr-1, which lacks the trans activation domain but retains the DNA-binding domain, in a B cell-specific manner. There was a decrease in B lymphopoiesis in the bone marrow accompanied by a reduction in splenic immature and mature B cells as well as marginal zone B cells in the transgenic mice. Moreover, transgenic mice respond poorly to BCR cross-linking in vitro and T-independent and T-dependent Ags in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802061      PMCID: PMC2592513          DOI: 10.4049/jimmunol.181.7.4590

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis.

Authors:  R Glynne; S Akkaraju; J I Healy; J Rayner; C C Goodnow; D H Mack
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

2.  Early growth response transcription factors are required for development of CD4(-)CD8(-) thymocytes to the CD4(+)CD8(+) stage.

Authors:  Michael Carleton; Mariëlle C Haks; Sigrid A A Smeele; Allan Jones; Stanley M Belkowski; Marc A Berger; Peter Linsley; Ada M Kruisbeek; David L Wiest
Journal:  J Immunol       Date:  2002-02-15       Impact factor: 5.422

3.  Thymocyte development in early growth response gene 1-deficient mice.

Authors:  Matthew Bettini; Hongkang Xi; Jeffrey Milbrandt; Gilbert J Kersh
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

Review 4.  Peripheral B cell subsets.

Authors:  David Allman; Shiv Pillai
Journal:  Curr Opin Immunol       Date:  2008-04-21       Impact factor: 7.486

5.  Impaired prostate tumorigenesis in Egr1-deficient mice.

Authors:  S A Abdulkadir; Z Qu; E Garabedian; S K Song; T J Peters; J Svaren; J M Carbone; C K Naughton; W J Catalona; J J Ackerman; J I Gordon; P A Humphrey; J Milbrandt
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

6.  Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages.

Authors:  K Krishnaraju; B Hoffman; D A Liebermann
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

Review 7.  B-lymphocyte quiescence, tolerance and activation as viewed by global gene expression profiling on microarrays.

Authors:  R Glynne; G Ghandour; J Rayner; D H Mack; C C Goodnow
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

8.  Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis.

Authors:  W G Tourtellotte; R Nagarajan; A Bartke; J Milbrandt
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes.

Authors:  Thierry Virolle; Anja Krones-Herzig; Veronique Baron; Giorgia De Gregorio; Eileen D Adamson; Dan Mercola
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

Review 10.  Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival.

Authors:  Eileen D Adamson; Dan Mercola
Journal:  Tumour Biol       Date:  2002 Mar-Apr
View more
  31 in total

1.  Inhibition of cell proliferation by CD44: Akt is inactivated and EGR-1 is down-regulated.

Authors:  L-S Zhang; H-W Ma; H J Greyner; W Zuo; M E Mummert
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

2.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

3.  Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma.

Authors:  L Tang; W Yu; Y Wang; H Li; Z Shen
Journal:  Clin Transl Oncol       Date:  2019-04-08       Impact factor: 3.405

Review 4.  Early growth response 1 (EGR1) activation in initial stages of host-pathogen interactions.

Authors:  Rajashri Banerji; Sunil D Saroj
Journal:  Mol Biol Rep       Date:  2021-03-30       Impact factor: 2.316

5.  Loss of transcription factor early growth response gene 1 results in impaired endochondral bone repair.

Authors:  Marie K Reumann; Olga Strachna; Sarah Yagerman; Daniel Torrecilla; Jihye Kim; Stephen B Doty; Lyudmila Lukashova; Adele L Boskey; Philipp Mayer-Kuckuk
Journal:  Bone       Date:  2011-06-25       Impact factor: 4.398

6.  Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.

Authors:  Kilannin Krysiak; Felicia Gomez; Brian S White; Matthew Matlock; Christopher A Miller; Lee Trani; Catrina C Fronick; Robert S Fulton; Friederike Kreisel; Amanda F Cashen; Kenneth R Carson; Melissa M Berrien-Elliott; Nancy L Bartlett; Malachi Griffith; Obi L Griffith; Todd A Fehniger
Journal:  Blood       Date:  2016-11-14       Impact factor: 22.113

7.  A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma.

Authors:  Kathryn T Bieging; Kamonwan Fish; Subbarao Bondada; Richard Longnecker
Journal:  Blood       Date:  2011-10-28       Impact factor: 22.113

8.  An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.

Authors:  K Nadira De Abrew; Norbert E Kaminski; Russell S Thomas
Journal:  Toxicol Sci       Date:  2010-09-06       Impact factor: 4.849

9.  Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.

Authors:  Jianjiang Ye; Lyndle Gradoville; George Miller
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

10.  Regulation of primary response genes in B cells.

Authors:  Trent Fowler; Hyunsuk Suh; Stephen Buratowski; Ananda L Roy
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.